Instrument Inactif

Communiqués Elekta AB (publ) Other OTC

Actions

EKTAY

US28617Y1010

Equipement et technologie médicale avancés

Communiqués

03/07	Elekta's Annual Report for 2025/26 available	AQ
28/05	Elekta : Year-end report, May - April Report	PU
18/05	Elekta : New research presented at ESTRO 2026 highlights advances in MR-guided radiotherapy	PU
05/03	Elekta : Q3, May - January Report	PU
25/02	Change in Elekta’s Nomination Committee for the Annual General Meeting 2026	AQ
23/01	Elekta : appoints Tomas Eliasson as Vice Chair of the Board	PU
16/01	Elekta receives FDA 510(k) clearance for Elekta Evo linear accelerator	AQ
12/01	Elekta : Invitation to Elekta's Strategic Update event on January 30	PU
26/11	Elekta : Q2, May - October Report	PU
26/11	Elekta : Second quarter, August-October 2025/26	PU
12/11	Elekta : Invitation to the presentation of Elekta's second quarter 2025/26	PU
31/10/25	Elekta : Nomination Committee for the Annual General Meeting 2026	PU
31/10/25	Elekta’s Nomination Committee for the Annual General Meeting 2026	AQ
09/10/25	Elekta : New impact report reveals radiotherapy's role in cancer care	PU
29/09/25	Elekta : Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer	PU
25/09/25	Elekta : marks two millionth patient treated with Leksell Gamma Knife radiosurgery	PU
08/09/25	Elekta announces changes in Executive Management	AQ
04/09/25	Report from the Annual General Meeting 2025 of Elekta	AQ
28/08/25	Elekta : Interim report, First quarter May-July 2025/26	PU
28/08/25	Elekta : Q1, May - July Report	PU
22/08/25	Elekta : Gamma Knife gave me peace of mind – and my life back	PU
21/08/25	Elekta : Investing in the next generation of radiation therapists	PU
15/08/25	Elekta : Notice of the Annual General Meeting 2025	PU
07/08/25	Elekta : Invitation to the presentation of Elekta's first quarter 2025/26	PU
01/08/25	Notice to the Annual General Meeting of Elekta AB (Publ)	AQ